MitrAssist Lifesciences announced clinical results for its new transthoracic heart valve (THV) system for TAVI procedures.

European Society of Cardiology (ESC) guidance advises that treatment should last for at least six weeks in patients with ...

MitrAssist Lifesciences, a leader in innovative cardiovascular medical devices, today unveiled the initial clinical results ...

Medically reviewed by Christopher Lee, MDA heart attack and stroke are both serious health conditions that occur when there's ...

A recent study published in Kidney Research and Clinical Practice has shed light on the impact of sacubitril-valsartan ...

Assessing right ventricular diastolic function is crucial in cardiac surgery, as it significantly impacts long-term prognosis. Typically, RV diastolic dysfunction is evaluated using criteria ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

The global intracardiac imaging market is on the brink of substantial expansion, with a projected compound annual growth rate ...

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased ...

It is notable that the ECG obtained at presentation showed the presumed sinus rhythm with first-degree atrioventricular block (PR interval, 230 milliseconds), along with right bundle-branch block and ...

The incidence of breast cancer has increased from 900 000 to 2.3 million new annual cases over the last 25 years. The 5-year ...

KEY POINTS A 35-year-old woman was admitted to a community hospital for sepsis caused by Streptococcus pyogenes bacteremia, ...